JPS5946287A - 新規１−オキサ−１−デチア−セフアロスポリン誘導体 - Google Patents

新規１−オキサ−１−デチア−セフアロスポリン誘導体

Info

Publication number
JPS5946287A
JPS5946287A JP57127574A JP12757482A JPS5946287A JP S5946287 A JPS5946287 A JP S5946287A JP 57127574 A JP57127574 A JP 57127574A JP 12757482 A JP12757482 A JP 12757482A JP S5946287 A JPS5946287 A JP S5946287A
Authority
JP
Japan
Prior art keywords
group
methyl
compound
formula
oxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57127574A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0352472B2 (enExample
Inventor
Masayuki Shibahara
聖至 柴原
Tsuneo Okonogi
小此木　恒夫
Yasushi Murai
村井　安
Shunzo Fukatsu
深津　俊三
Taro Niida
仁井田　太郎
Tadashi Wakazawa
若沢　正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Merck and Co Inc
Original Assignee
Meiji Seika Kaisha Ltd
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd, Merck and Co Inc filed Critical Meiji Seika Kaisha Ltd
Priority to JP57127574A priority Critical patent/JPS5946287A/ja
Priority to US06/515,422 priority patent/US4534898A/en
Priority to PH29252A priority patent/PH21016A/en
Priority to EP83107150A priority patent/EP0099580B1/en
Priority to DE8383107150T priority patent/DE3374061D1/de
Priority to IN911/CAL/83A priority patent/IN159071B/en
Priority to KR1019830003411A priority patent/KR890001489B1/ko
Publication of JPS5946287A publication Critical patent/JPS5946287A/ja
Priority to PH32495A priority patent/PH21657A/en
Publication of JPH0352472B2 publication Critical patent/JPH0352472B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57127574A 1982-07-23 1982-07-23 新規１−オキサ−１−デチア−セフアロスポリン誘導体 Granted JPS5946287A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP57127574A JPS5946287A (ja) 1982-07-23 1982-07-23 新規１−オキサ−１−デチア−セフアロスポリン誘導体
US06/515,422 US4534898A (en) 1982-07-23 1983-07-20 1-Oxa-1-dethia-cephalosporin derivatives
PH29252A PH21016A (en) 1982-07-23 1983-07-20 2-alkyl-1-oxa-dethia-cephalosporin derivatives and process for producing said compound
EP83107150A EP0099580B1 (en) 1982-07-23 1983-07-21 New 1-oxa-1-dethia-cephalosporin derivatives
DE8383107150T DE3374061D1 (en) 1982-07-23 1983-07-21 New 1-oxa-1-dethia-cephalosporin derivatives
IN911/CAL/83A IN159071B (enExample) 1982-07-23 1983-07-22
KR1019830003411A KR890001489B1 (ko) 1982-07-23 1983-07-23 1-옥사-1-데티아-세팔로스포린 유도체 및 그 중간 화합물의 제조방법
PH32495A PH21657A (en) 1982-07-23 1985-07-09 7b-amino-2-alkyl-1-oxa-1 dethiacephalosporin compounds and process for preparing said compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57127574A JPS5946287A (ja) 1982-07-23 1982-07-23 新規１−オキサ−１−デチア−セフアロスポリン誘導体

Publications (2)

Publication Number Publication Date
JPS5946287A true JPS5946287A (ja) 1984-03-15
JPH0352472B2 JPH0352472B2 (enExample) 1991-08-12

Family

ID=14963413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57127574A Granted JPS5946287A (ja) 1982-07-23 1982-07-23 新規１−オキサ−１−デチア−セフアロスポリン誘導体

Country Status (1)

Country Link
JP (1) JPS5946287A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286315A (en) * 1989-03-30 1994-02-15 Nippon Steel Corporation Process for preparing rollable metal sheet from quenched solidified thin cast sheet as starting material

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS535193A (en) * 1976-06-28 1978-01-18 Fujisawa Pharmaceut Co Ltd 2-alkyl-7-substituted-2 or 3-cephem-4-carboxlic acids, their salts and their preparation
JPS53135997A (en) * 1977-04-28 1978-11-28 Shionogi & Co Ltd Haloarylmalonamide oxacephalosporin
JPS549296A (en) * 1977-04-02 1979-01-24 Hoechst Ag Cephem derivative and its preparation
JPS5484590A (en) * 1977-12-13 1979-07-05 Fujisawa Pharmaceut Co Ltd 2-methyl-7-substituted-2 or 3-cephem-4-carboxylic acid, its salt, and their preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS535193A (en) * 1976-06-28 1978-01-18 Fujisawa Pharmaceut Co Ltd 2-alkyl-7-substituted-2 or 3-cephem-4-carboxlic acids, their salts and their preparation
JPS549296A (en) * 1977-04-02 1979-01-24 Hoechst Ag Cephem derivative and its preparation
JPS53135997A (en) * 1977-04-28 1978-11-28 Shionogi & Co Ltd Haloarylmalonamide oxacephalosporin
JPS5484590A (en) * 1977-12-13 1979-07-05 Fujisawa Pharmaceut Co Ltd 2-methyl-7-substituted-2 or 3-cephem-4-carboxylic acid, its salt, and their preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286315A (en) * 1989-03-30 1994-02-15 Nippon Steel Corporation Process for preparing rollable metal sheet from quenched solidified thin cast sheet as starting material

Also Published As

Publication number Publication date
JPH0352472B2 (enExample) 1991-08-12

Similar Documents

Publication Publication Date Title
US4264595A (en) 7-[2-(2-Imino-4-thiazolin-4-yl)-2-(syn)-hydroxy-iminoacetamido]-cephalosporins
JPS58174387A (ja) 化学化合物
JPS59219292A (ja) 有機化合物
JPH05502884A (ja) 新規３―置換セフェム化合物及びその製造方法
KR920004820B1 (ko) 새로운 세팔로스포린 유도체의 제조방법
SE450384B (sv) Nya cefemforeningar och forfarande for deras framstellning
HU204277B (en) Process for producing 7-(2-65-amino-1,2,4-thiadiazol-3-yl/-2-imino-acetamido/-3-(3-halogeno-1- -propen-1-yl)-ceph-3-eme-4-carboxylates
US4245088A (en) Novel 3-acyloxymethyl-cephem compounds useful as intermediates for preparing cephalosporin antibiotics
JPS5951292A (ja) セファロスポリン化合物
EP0272487A1 (en) Cephalosporin derivatives and their crystalline derivatives, process for the preparation of the same, intermediates for use in the synthesis of the same, pharmaceutical compositions comprising the same, and the use of the same for the manufacture of a medicament having valuable therapeutic and preventative properties
JP3143829B2 (ja) ７−アシル−３−置換カルバモイルオキシセフェム化合物及びその製法
CA1065304A (en) PROCESS FOR PREPARING 7.beta.-ACYLAMINO-7.alpha.-ALKOXYCEPHALOSPORINS
JPS62491A (ja) ３−（置換）プロペニルアミノチアゾリルセフアロスポラン酸およびそのエステル
JPS5946287A (ja) 新規１−オキサ−１−デチア−セフアロスポリン誘導体
KR890001489B1 (ko) 1-옥사-1-데티아-세팔로스포린 유도체 및 그 중간 화합물의 제조방법
JPS6011490A (ja) β−ラクタム誘導体
JPS59118792A (ja) セフエム化合物
US4239758A (en) Cephalosporins
JPH0742291B2 (ja) ３‐エキソメチレンセファム誘導体の製造方法
JPH06500788A (ja) セファロスポリン誘導体およびそれらの同族体
JPH04266889A (ja) 抗生物質ｃ−３カテコ−ル−置換セファロスボリン化合物、組成物およびその使用法
JPS6322570A (ja) １−メタンスルホニルオキシ−６−トリフルオロメチル−１ｈ−ベンゾトリアゾ−ル及びセファロスポリン誘導体の製造方法
US4238608A (en) 7-[2-(2-Aminothiazol-4-yl)-2-substituted thio-acetamido] cephalosporins
SU1500163A3 (ru) Способ получени карбоксиалкенамидоцефалоспоринов, или их сложных эфиров, или их солей с щелочными металлами
JPS61251685A (ja) 新規な１−オキサ−１−デチアセフアロスポリン化合物及びそれを含む抗菌剤